You are here: Industry Insights > nasal spray

News List

Which one of new dosage forms of nasal spray vaccine for COVID-19 will be successful? PharmaSources/Big Cat of Medical Field
August 06, 2021
According to the latest news on March 24, 2021 (last week), CanSino (688185.SH, 06185.HK) inhaled COVID-19 vaccine was approved by the National Medical Products Administration.
Glenmark gets US FDA nod for nasal spray to treat seasonal allergic rhinitis ExpressPharma
January 14, 2022
With this NDA approval, the company looks forward to bringing this new medicine to physicians and their patients for the treatment of symptoms of seasonal allergic rhinitis...
ITC starts clinical trials of nasal spray for COVID-19 prevention ExpressPharma
November 26, 2021
ITC yesterday confirmed that it is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.
NEWS Anti-viral COVID-19 nasal spray to be commercialised in Birmingham EuropeanPharmaceuticalReview
November 10, 2021
Birmingham Biotech and the University of Birmingham, both UK, have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
/C O R R E C T I O N -- pHOXBIO/ prnasia
September 28, 2021
In the news release, pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2, issued Sept. 22, 2021 by pHOXBIO...
Glenmark inks agreement with SaNOtize to commercialise nasal spray for COVID-19 treatment in India and other Asian markets expresspharma
August 03, 2021
Nitric oxide (NO) has anti-microbial properties with a direct proven effect on SARS-CoV-2.
Nanopharm, Leyden Labs to Develop Nasal Spray Drugs contractpharma
July 23, 2021
Intranasal spray product candidates will target known and new respiratory viruses.
Trial to assess antimicrobial nasal spray in treating mild COVID-19 europeanpharmaceuticalreview
May 18, 2021
The study will assess whether APR-AOS2020 can reduce the viral load of recently infected COVID-19 patients with mild symptoms.
Nasal spray shown to be effective in reducing COVID-19 transmission europeanpharmaceuticalreview
May 07, 2021
The algae-derived NasitrolTM nasal spray reduced the incidence of COVID-19 in intensive care unit (ICU) workers to one percent in a clinical trial.
Glenmark’s Ryaltris nasal spray gets approval in Europe for treatment of allergic rhinitis expresspharma
April 27, 2021
It is a novel fixed-dose combination nasal spray of an anti-histamine and a steroid, indicated for treatment of symptoms associated with allergic rhinitis (AR) in patients over 12 years of age.

Previous page 1 2 3 4 Next page